Delivery Order SPE2DR25D2003-SPE2DR26FR09C
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Trokendi XR 25 mg capsules (30-count) valued at $1,476.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by May 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $25,401.53 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count units) under a firm fixed-price contract type. The award was made on November 6, 2025, with an ultimate completion date of November 7, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count). This firm fixed-price, competitively awarded contract with no set-aside designation was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count) under a firm fixed-price contract valued at $2,530.13. The award was issued on December 31, 2025, with an ultimate completion date of January 2, 2026. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) with a ceiling value of $6,003.28. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 17, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,115.29 by the Defense Logistics Agency (DLA) on November 26, 2025, for the supply of Trokendi XR 200 mg capsules in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 28, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,581.56 to AmerisourceBergen Drug Corp for Trokendi XR 100 mg capsules (30-count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order, which was not set aside for small business, represents a competitively awarded pharmaceutical supply transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trokendi XR 100 mg capsules (30-count). The contract ceiling value is $1,304.52, with an ultimate completion date of May 13, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Trokendi XR 100 mg capsules (30-count) under a firm fixed-price contract with a ceiling value of $2,726.20. This is a non-set-aside competitive award with an ultimate completion date of December 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules (30-count) with a ceiling value of $2,995.93. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 8, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR09CDelivery Order
The Defense Logistics Agency awarded a $7,551.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Trokendi XR 100 mg capsules on January 12, 2026, with completion due by January 13, 2026. This award was made without a set-aside designation on a fully competitive basis. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across the military and veteran healthcare systems. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary indefinite delivery contract with DLA and maintains the capability to efficiently fulfill government requirements for essential pharmaceutical and medical commodities. Trokendi XR is an extended-release anticonvulsant medication used in military treatment facilities and federal healthcare institutions to support patient care requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 1/11/26 |